Using this cut-off, we performed a groupwise comparison, which showed that patients with B7-H3high expression at diagnosis did not differ significantly from patients with B7-H3low expression in terms of their age, sex and AML occurrence (primary/secondary) distribution, nor in their WBC, Hb and Plt counts (Table 2). Here, GSTM1 is linked to acute myeloid leukemia.